Sundowning syndrome in aging and dementia: Research in mouse models

Both normal aging and dementia are associated with altered circadian regulation of physiology and behavior. Elderly individuals and dementia patients commonly experience disrupted sleep-wake cycles, which may lead to psychomotor agitation, confusion, and wandering. These behaviors are disruptive to both patients and caregivers. Sundowning syndrome, which encompasses many of these behaviors, is characterized by a temporal pattern in the severity of symptoms, usually expressed as worse during the late afternoon or evening. Other than antipsychotic medications, off-label medications, and restraint, few treatment options are available. The aim of this paper is to review mouse studies of circadian behavioral disturbances relevant to sundowning, in order to determine potential models for studying the mechanisms of sundowning syndrome. The emergence of a useful mouse model should facilitate the development of novel therapeutic approaches.

[1]  J. Brioni,et al.  Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. , 1993, European journal of pharmacology.

[2]  D. O'Connor,et al.  A survey of Australian and New Zealand old age psychiatrists' preferred medications to treat behavioral and psychological symptoms of dementia (BPSD) , 2005, International Psychogeriatrics.

[3]  D. Kunz,et al.  Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy. , 2004, Journal of clinical psychopharmacology.

[4]  B. Costall,et al.  Muscarinic antagonists are anxiogenic in rats tested in the black-white box , 1996, Pharmacology Biochemistry and Behavior.

[5]  S. Ancoli-Israel,et al.  Illumination levels in nursing home patients: effects on sleep and activity rhythms , 2000, Journal of sleep research.

[6]  R. Nelson,et al.  Potential animal models of seasonal affective disorder , 2011, Neuroscience & Biobehavioral Reviews.

[7]  Van Someren EJ Circadian and sleep disturbances in the elderly. , 2000, Experimental gerontology.

[8]  N. Kutner,et al.  Observed sleep/wakefulness and severity of dementia in an Alzheimer's disease special care unit. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.

[9]  Rochelle E Tractenberg,et al.  The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease , 2003, Journal of sleep research.

[10]  Kristine Yaffe,et al.  Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. , 2003, JAMA.

[11]  J R Hodges,et al.  Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. , 2004, Brain : a journal of neurology.

[12]  W N Charman,et al.  Age, lens transmittance, and the possible effects of light on melatonin suppression. , 2003, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[13]  Dick F Swaab,et al.  Melatonin rhythmicity: effect of age and Alzheimer's disease , 2003, Experimental Gerontology.

[14]  D. Pfaff,et al.  Definition of Arousal and Mechanistic Studies in Intact and Brain‐Damaged Mice , 2009, Annals of the New York Academy of Sciences.

[15]  S. Tufik,et al.  Anxiogenic effect of sleep deprivation in the elevated plus-maze test in mice , 2004, Psychopharmacology.

[16]  G. Stoppe,et al.  Treatment of rest‐activity disorders in dementia and special focus on sundowning , 2005, International journal of geriatric psychiatry.

[17]  Sonia Ancoli-Israel,et al.  Increased Light Exposure Consolidates Sleep and Strengthens Circadian Rhythms in Severe Alzheimer's Disease Patients , 2003, Behavioral sleep medicine.

[18]  A. Cadete-Leite,et al.  Basal forebrain neurons modulate the synthesis and expression of neuropeptides in the rat suprachiasmatic nucleus , 2004, Neuroscience.

[19]  Gary L. Wenk,et al.  The Nucleus Basalis Magnocellularis Cholinergic System: One Hundred Years of Progress , 1997, Neurobiology of Learning and Memory.

[20]  Shelley Peacock,et al.  Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia. , 2009, The Cochrane database of systematic reviews.

[21]  T. Balkin,et al.  The effects of sleep deprivation on symptoms of psychopathology in healthy adults. , 2007, Sleep medicine.

[22]  D. Coakley,et al.  BEHAVIOUR DISTURBANCE AND OTHER PREDICTORS OF CARER BURDEN IN ALZHEIMER'S DISEASE , 1997, International journal of geriatric psychiatry.

[23]  C. Pollak,et al.  Sleep Problems and Institutionalization of the Elderly , 1991, Journal of geriatric psychiatry and neurology.

[24]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[25]  S. Klaffke,et al.  Sundowning and circadian rhythm disorders in dementia. , 2006, Acta neurologica Belgica.

[26]  G. Stoppe,et al.  Behavioural Problems Associated With Dementia , 1999, Drugs & aging.

[27]  S. Borson,et al.  Sleep Disturbances in Patients with Alzheimer’s Disease , 2001, CNS drugs.

[28]  B. Rovner,et al.  Sedative-hypnotic use by the elderly: Effects on hospital length of stay and costs , 1997, The journal of mental health administration.

[29]  S. Henriksen,et al.  Age-independent and age-related deficits in visuospatial learning, sleep–wake states, thermoregulation and motor activity in PDAPP mice , 2002, Brain Research.

[30]  D. Cardinali,et al.  Clinical Aspects of Melatonin Intervention in Alzheimer’s Disease Progression , 2010, Current neuropharmacology.

[31]  M. Biel,et al.  Melanopsin and rod–cone photoreceptive systems account for all major accessory visual functions in mice , 2003, Nature.

[32]  B. C. Manning,et al.  Sundowning and circadian rhythms in Alzheimer's disease. , 2001, The American journal of psychiatry.

[33]  L. Evans Sundown Syndrome in Institutionalized Elderly , 1987, Journal of the American Geriatrics Society.

[34]  Dov Zohar,et al.  The effects of sleep loss on medical residents' emotional reactions to work events: a cognitive-energy model. , 2005, Sleep.

[35]  C. Colwell,et al.  Age-Related Decline in Circadian Output , 2011, The Journal of Neuroscience.

[36]  D. Rokicki,et al.  The anxiolytic-like effect of nicotine undergoes rapid tolerance in a model of contextual fear conditioning in rats , 2001, Pharmacology Biochemistry and Behavior.

[37]  C. Pollak,et al.  Sleep problems in the community elderly as predictors of death and nursing home placement , 1990, Journal of Community Health.

[38]  Raymond Cluydts,et al.  The emotional brain and sleep: an intimate relationship. , 2010, Sleep medicine reviews.

[39]  R. Nelson,et al.  Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice , 2011, Proceedings of the National Academy of Sciences.

[40]  S. File,et al.  Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. , 1999, Behavioural pharmacology.

[41]  D. Cameron Studies in senile nocturnal delirium , 1941 .

[42]  B. Sommer,et al.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Kazuo Nakamura,et al.  Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam , 1998 .

[44]  Sang Joon Son,et al.  Sundown Syndrome in Persons with Dementia: An Update , 2011, Psychiatry investigation.

[45]  L. Burgio,et al.  Studying disruptive vocalization and contextual factors in the nursing home using computer-assisted real-time observation. , 1994, Journal of gerontology.

[46]  D J Foley,et al.  Sleep complaints among elderly persons: an epidemiologic study of three communities. , 1995, Sleep.

[47]  Randy J. Nelson,et al.  Dim light at night provokes depression-like behaviors and reduces CA1 dendritic spine density in female hamsters , 2011, Psychoneuroendocrinology.

[48]  I. Weiner,et al.  Scopolamine Induces Disruption of Latent Inhibition which is Prevented by Antipsychotic Drugs and an Acetylcholinesterase Inhibitor , 2007, Neuropsychopharmacology.

[49]  P. Mcgeer,et al.  Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain , 1984, Neurology.

[50]  R. J. Rodgers,et al.  Effects of scopolamine and its quaternary analogue in the murine elevated plus‐maze test of anxiety , 1995, Behavioural pharmacology.

[51]  Richard E. Kronauer,et al.  Dose-response relationships for resetting of human circadian clock by light , 1996, Nature.

[52]  Kathryn A. Lee,et al.  Sleep and “sundowning” in nursing home patients with dementia , 1993, Psychiatry Research.

[53]  L. Burgio,et al.  Temporal patterns of disruptive vocalization in elderly nursing home residents , 2001, International journal of geriatric psychiatry.

[54]  H. Nygaard,et al.  Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil , 2000, International journal of geriatric psychiatry.

[55]  A. Satlin,et al.  Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. , 1992, The American journal of psychiatry.

[56]  S. Engelborghs,et al.  Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances , 2004, The European journal of neuroscience.

[57]  Jeanne F Duffy,et al.  Light Exposure Patterns in Healthy Older and Young Adults , 2010, Journal of biological rhythms.

[58]  B. Boeve,et al.  Sleep Disturbance in Dementia with Lewy Bodies and Alzheimer’s Disease: A Multicenter Analysis , 2011, Dementia and Geriatric Cognitive Disorders.

[59]  S. Ancoli-Israel,et al.  CIRCADIAN RHYTHMS OF AGITATION IN INSTITUTIONALIZED PATIENTS WITH ALZHEIMER'S DISEASE , 2000, Chronobiology international.

[60]  S. Finkel,et al.  Introduction to behavioural and psychological symptoms of dementia (BPSD) , 2000, International journal of geriatric psychiatry.

[61]  B. V. van Munster,et al.  Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review , 2010, International journal of geriatric psychiatry.

[62]  D. Swaab,et al.  The human pineal gland and melatonin in aging and Alzheimer's disease , 2005, Journal of pineal research.

[63]  Gill Livingston,et al.  Anxiety and depression in family caregivers of people with Alzheimer disease: the LASER-AD study. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[64]  LuAnn Nowak,et al.  A qualitative examination of the phenomenon of sundowning. , 2007, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.

[65]  P. Rabins,et al.  "Sundowning" and other temporally associated agitation states in dementia patients. , 2006, Annual review of medicine.

[66]  R. Hébert,et al.  The contribution of neuropsychiatric symptoms to the cost of dementia care , 2006, International journal of geriatric psychiatry.

[67]  G. ÓLaighin,et al.  Validating a new clinical subtyping scheme for delirium with electronic motion analysis , 2010, Psychiatry Research.

[68]  Jiska Cohen-Mansfield,et al.  Temporal patterns of agitation in dementia. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[69]  F. Pasquier,et al.  Sundowning syndrome in demented patients without neuroleptic therapy. , 1996, Archives of gerontology and geriatrics.

[70]  J. Szyndler,et al.  The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia , 2000, Journal of Neural Transmission.

[71]  C. McClung,et al.  Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges , 2009, Brain Research Reviews.

[72]  M. Mattson,et al.  3xTgAD mice exhibit altered behavior and elevated Aβ after chronic mild social stress , 2012, Neurobiology of Aging.

[73]  N. Tarrier,et al.  Determinants of carer stress in Alzheimer's disease , 1998, International journal of geriatric psychiatry.

[74]  Lon S Schneider,et al.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. , 2005, JAMA.

[75]  D. Garfinkel,et al.  Melatonin for treatment of sundowning in elderly persons with dementia - a preliminary study. , 2000, Archives of gerontology and geriatrics.

[76]  J. Yesavage,et al.  The Relations among Caregiver Stress, “Sundowning” Symptoms, and Cognitive Decline in Alzheimer's Disease , 1992, Journal of the American Geriatrics Society.

[77]  D. Bonthron,et al.  PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model , 1991, Cell.